Literature DB >> 14522833

Nuclear transfer of adult bone marrow mesenchymal stem cells: developmental totipotency of tissue-specific stem cells from an adult mammal.

Yoko Kato1, Hideaki Imabayashi, Taisuke Mori, Tetsuya Tani, Masanori Taniguchi, Mikihiko Higashi, Michio Matsumoto, Akihiro Umezawa, Yukio Tsunoda.   

Abstract

Recent studies have demonstrated that somatic stem cells have a flexible potential greater than previously expected when they are transplanted into different tissues. On the other hand, recent studies also have revealed that these potentials might occur because of spontaneous cell fusion with recipient cells. The nuclei of somatic cells could have been reprogrammed when they were artificially or spontaneously fused with mouse embryonic stem (ES) cells. The resultant hybrid cells acquired a developmental pluripotency that the original somatic cells did not have but that ES cells did. LaBarge and Blau (Cell 2002; 111:589-601) demonstrated that adult bone marrow-derived cells contributed to muscle tissue in a stepwise biological progression. This means that bone marrow-derived cells became satellite cells of mononucleate muscle stem cells after the first irradiation-induced damage to the mouse, and after the second irradiation-induced damage, multinucleate myofibers appeared from the bone marrow-derived cells. Considered together, the differentiation potential of the somatic stem cell nucleus itself remains unclear. Although the pluripotency of somatic stem cell populations has been evaluated, the developmental totipotency of the nuclei of somatic stem cells, whether or not they fused with other cells, has not been shown, except in only one study concerning fetal neural cells (never in adult stem cells). Here, we showed the developmental totipotency of adult bovine mesenchymal stem cells by nuclear transfer.

Entities:  

Mesh:

Year:  2003        PMID: 14522833     DOI: 10.1095/biolreprod.103.020271

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  Isolation, culture, and induced multiple differentiation of Mongolian sheep bone marrow-derived mesenchymal stem cells.

Authors:  Zongzheng Liu; Wei Wang; Jinfang Gao; Huanmin Zhou; Yanru Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-08       Impact factor: 2.416

2.  Mice cloned from skin cells.

Authors:  Jinsong Li; Valentina Greco; Géraldine Guasch; Elaine Fuchs; Peter Mombaerts
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

3.  Constitutive expression of the embryonic stem cell marker OCT4 in bovine somatic donor cells influences blastocysts rate and quality after nucleus transfer.

Authors:  Lleretny Rodríguez-Alvarez; Jose Manriquez; Alejandra Velasquez; Fidel Ovidio Castro
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-07-12       Impact factor: 2.416

4.  Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

Authors:  Seung-Ha Yang; Min-Jung Park; Il-Hee Yoon; Su-Young Kim; So-Hee Hong; Jin-Young Shin; Hye-Young Nam; Yong-Hee Kim; Bongi Kim; Chung-Gyu Park
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

5.  Application of a novel population of multipotent stem cells derived from skin fibroblasts as donor cells in bovine SCNT.

Authors:  Shaohui Pan; Wuju Chen; Xu Liu; Jiajia Xiao; Yanqin Wang; Jun Liu; Yue Du; Yongsheng Wang; Yong Zhang
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

6.  In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors.

Authors:  Ramiro Olivera; Lucia Natalia Moro; Roberto Jordan; Carlos Luzzani; Santiago Miriuka; Martin Radrizzani; F Xavier Donadeu; Gabriel Vichera
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

Review 7.  An Update on Applications of Cattle Mesenchymal Stromal Cells.

Authors:  Barbara Merlo; Penelope Maria Gugole; Eleonora Iacono
Journal:  Animals (Basel)       Date:  2022-08-02       Impact factor: 3.231

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.